Y-mAbs Therapeutics, Inc. - Common Stock (NQ:YMAB)
4.230
+0.060
(+1.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 20, 2025
Add to My Watchlist
All News about Y-mAbs Therapeutics, Inc. - Common Stock
Via Benzinga
Preview: Y-mAbs Therapeutics's Earnings
May 12, 2025
Via Benzinga
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 22, 2025
Via Benzinga
Via Benzinga

Via Benzinga

Decoding 5 Analyst Evaluations For Y-mAbs Therapeutics
December 05, 2024
Via Benzinga

Beyond The Numbers: 4 Analysts Discuss Y-mAbs Therapeutics Stock
November 18, 2024
Via Benzinga
Earnings Scheduled For May 13, 2025
May 13, 2025
Via Benzinga
Via Benzinga



Examining the Future: Y-mAbs Therapeutics's Earnings Outlook
November 07, 2024
Via Benzinga

Navigating 8 Analyst Ratings For Y-mAbs Therapeutics
September 09, 2024
Via Benzinga

Via Benzinga

Via Benzinga

Earnings Scheduled For March 4, 2025
March 04, 2025
Via Benzinga











12 Health Care Stocks Moving In Friday's Pre-Market Session
March 01, 2024
Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session
February 29, 2024
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free